Midiana (Drospirenone, Ethinylestradiol)

The combination of drospirenone and ethinylestradiol suppresses the release of luteinising hormone and follicle‑stimulating hormone, preventing ovulation. Drospirenone also thickens cervical mucus and alters the endometrium, creating conditions that are unfavorable for fertilisation and implantation.

The dosing regimen for Midiana is determined by the prescribing healthcare professional. Typically, it is taken once daily at the same time each day, but the exact schedule and duration are set by the prescriber based on individual patient needs.

Midiana is contraindicated in pregnancy (Category X) and should not be started or continued if a woman becomes pregnant. It is generally not recommended during breastfeeding because hormonal contraceptives can affect milk production and infant exposure.

To order Midiana, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Midiana contains drospirenone, a progestin with anti‑androgenic and mild diuretic properties, which may offer benefits such as reduced water retention and improved acne control compared with older progestins. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives when taken correctly.

Midiana tablets should be stored at temperatures below 25 °C, in the original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

Midiana is taken orally, usually as a single tablet each day at the same time. It is important to follow the prescriber’s instructions and to start a new pack after a 7‑day hormone‑free interval, unless directed otherwise.

Serious risks include venous thromboembolism, arterial thrombosis (such as stroke or myocardial infarction), severe hypertension, liver disorders, and rare allergic reactions. Patients should seek immediate medical attention if they experience symptoms such as unexplained leg pain, chest pain, severe headache, or signs of an allergic reaction.

Midiana should not be used by women who are pregnant, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, known or suspected breast cancer, or who smoke heavily (more than 15 cigarettes per day) and are over 35 years old. It is also contraindicated in individuals with known hypersensitivity to any component of the product.